Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To compare individual active drugs (antidepressants and benzodiazepines) and placebo in terms of efficacy and acceptability in the acute treatment of panic disorder, with or without agoraphobia. To rank individual active drugs for panic disorder (antidepressants, benzodiazepines and placebo) according to their effectiveness and acceptability. To explore heterogeneity and inconsistency between direct and indirect evidence in the network meta-analyses.

Original publication

DOI

10.1002/14651858.CD012729.pub2

Type

Journal article

Journal

Cochrane Database of Systematic Reviews

Publication Date

28/10/2020

Volume

2020